• 1
    Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy in local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997; 5: 24832493.
  • 2
    Fisher B, Bryant J, Wolmark N, et al. The effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998; 16: 26722685.
  • 3
    Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine year results from NSABP B-18. J Natl Cancer Inst Monogr. 2001; 30: 96102.
  • 4
    Hsu SM, Raine L, Fanger HA. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison of ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem. 1981; 29: 577580.
  • 5
    Fisher ER. Identification of risk factors by conventional pathologic and some ancillary techniques in women with breast cancer. In: RagazJ, ArielIM, editors. High-risk breast cancer. New York: Springer-Verlag, 1989: 233250.
  • 6
    Fisher ER, Gregorio R, Redmond C, Dekker A, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project Protocol 4. II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer. Am J Clin Pathol. 1976; 65: (1): 2130.
  • 7
    Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978; 42: 2025-2031.
  • 8
    Fisher ER, Palekar A, Rockette H, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) V. Significance of axillary nodal micro and macrometastases. Cancer. 1978; 42: 20322038.
  • 9
    Fisher ER. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin. 1997; 47: 5264.
  • 10
    Feldman LD, Hortabagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathologic assessment of response to induction chemotherapy in breast cancer. Cancer Res. 1986; 46: 25782581.
  • 11
    Briffod M, Spyratos F, Tubiana-Hilin M, et al. Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression. Cancer. 1989; 63: 631637.
  • 12
    Spyratos F, Briffod M, Tubiana-Hulin M, et al. Sequential cytopunctures during preoperative chemotherapy for primary tumor regression, and short-term follow-up. Cancer. 1992; 69: 470475.
  • 13
    Kennedy S, Merino MH, Swain SM, Lippman ME. The effects of hormonal and chemotherapy on tumoral and non-neoplastic breast tissue. Hum Pathol. 1990; 21: 192198.
  • 14
    Frank GA, Volchenko NN, Borisov VI. Chemotherapeutic pathomorphosis of breast cancer. Sov Med. 1990; 11: 1416.
  • 15
    Rasbridge SA, Gillett CE, Seymour AM, et al. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer. 1994; 70: 335341.
  • 16
    Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg. 1995; 180: 297306.
  • 17
    Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol. 1996; 9: 893900.
  • 18
    Aktepe F, Kapucuoglu N, Pak I. The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology. 1996; 29: 6367.
  • 19
    Chollet P, Charrier S, Brain E. Clinical and pathological response to primary chemotherapy in operable breast cancer. Eur J Cancer. 1997; 33: 862866.
  • 20
    Moll UM, Chumas J. Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract. 1997; 193: 187196.
  • 21
    Tomczykowski J, Szubstarski F, Kurylcio L, Stanislawek A, Barycki J, Baranowski W. Does the degree of cell lesion in breast cancer after inductive chemotherapy have any prognostic value? Acta Oncol. 1999; 38: 949953.
  • 22
    Rosen PP. Rosen's breast pathology. Philadelphia: Lippincott-Raven, 1997: 779787.
  • 23
    Tavassoli FA. Pathology of the breast. 2nd edition. Stamford, CT: Appleton-Lange, 1999: 420426.
  • 24
    Cajulis RS, Hessel RG, Frias-Hidvegi D, Yu GH. Cytologic grading of fine needle aspirates of breast carcinoma by private practice pathologists. Acta Cytol. 1997; 41: 313320.
  • 25
    Fisher ER, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation. Cancer. 1983; 51: 181191.
  • 26
    Fisher ER, Gregorio RM, Fisher B. The pathology of invasive breast cancer: a syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol No 4). Cancer. 1975; 36: 185.
  • 27
    Fisher ER, Redmond C, Fisher B. Histologic grading of breast cancer. Pathol Annu. 1980; 15: 239251.
  • 28
    Gardin G, Alama A, Rosso R, et al. Relationship of variations in tumor kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Res Treat. 1994; 32: 311318.
  • 29
    Amadori D, Volpi A, Maltoni NO, et al. Cell proliferation as a predictor of response to chemotherapy in metastatic breast carcinoma: a prospective study. Breast Cancer Res Treat. 1997; 43: 714.
  • 30
    Remvikos Y, Jouve M, Beuzeboc P, Viehl P, Magdelenat H, Pouillart P. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates. Eur J Cancer. 1993; 29: 18431848.
  • 31
    Daidone MG, Silvestrini R, Luisi A, et al. Changes in biological markers after primary chemotherapy for breast cancers. Int J Cancer. 1995; 61: 301305.
  • 32
    Levan A. Chromosomes in cancer tissue. Ann N Y Acad Sci. 1956; 63: 774789.
  • 33
    Grafi G. Cell cycle regulation of DNA replication: the endoreduplication perspective. Exp Cell Res. 1998; 244: 372-378.
  • 34
    Fisher B, Fisher ER. Effect of experimental perfusion upon the biologic and pathologic behavior of tumors. Surgery. 1964; 56: 651662.
  • 35
    Frassoldati A, Adami F, Banzi C, Criscuolo M, Piccinini L, Silingardi V. Changes of biological features in breast cancer cells determined by primary chemotherapy. Breast Cancer Res Treat. 1997; 44: 185192.
  • 36
    Lipponen P, Aaltomaa S, Kosma VM, Syrjanen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer. 1994; 30: 20682073.
  • 37
    Fisher ER, Gregorio RM, Redmond C, Kim WS, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) III. The significance of extranodal extension of axillary metastases. Am J Clin Pathol. 1976; 65: 429445.
  • 38
    Donegan W, Stine S, Samier T. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer. 1993; 72: 778782.
  • 39
    Hetelekidis S, Schnitt SJ, Silver B, et al. The significance of extracapsular extension of axillary lymph node metastases in early stage breast cancer. Int J Radiat Oncol Biol Phys. 2000; 46: 3134.
  • 40
    Leonard C, Corkill M, Tomkin J, et al. Are axillary recurrence and overall survival affected by axillary extranodal tumor extension of breast cancer? Implications for radiotherapy. J Clin Oncol. 1995; 13: 4753.
  • 41
    Fisher BJ, Perera FE, Cooke AL, et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Int J Radiat Oncol Biol Phys. 1997; 38: 551559.
  • 42
    Dowlatashahi K, Fan M, Snider HC. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997; 80: 11881197.
  • 43
    Rose DM, Giuliano AE. Micrometastatic nodal disease in breast cancer: the dilemma continues. J Surg Oncol. 2000; 74: 8789.
  • 44
    Leong A. The prognostic dilemma of nodal micrometastases in breast carcinoma. Jan To Kagaku Ryoho. 2000; 27: 315320.
  • 45
    Neville AM, Price KN, Gelber RD, Goldhirsch A. Axillary node micrometastases and breast cancer. Lancet. 1991; 337: 1110.
  • 46
    Hartveit F, Lilleng PK. Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathology. 1996; 28: 241246.
  • 47
    Lilleng PK, Hartveit F. “Missed” micrometastases. The extent of the problem. Acta Oncol. 2000; 39: 313317.